Levamisole
- Generic Name
- Levamisole
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H12N2S
- CAS Number
- 14769-73-4
- Unique Ingredient Identifier
- 2880D3468G
- Background
Levamisole is an antihelminthic drug that was commonly used for the treatment of parasitic, viral, and bacterial infections. It was manufactured by Janssen and first used in 1969 as an agent to treat worm infestations Levamisole was approved by the FDA in 1990 as an adjuvant treatment for colon cancer. Prior to this, levamisole was used as an antirheumatic ...
- Indication
For adjuvant treatment in combination with fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. Also used to treat malignant melanoma and head/neck cancer.
- Associated Conditions
- Adenocarcinoma of Colon, Ancylostoma duodenale infection, Ascaris lumbricoides infection, Colorectal Carcinoma (CRC), Enterobius vermicularis infection, Necatoriasis due to necator americanus, Strongyloides Stercoralis Infection, Trichuris Infection
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath